Gau Wey - Chuan - Mar 29, 2023 Form 4 Insider Report for Maxpro Capital Acquisition Corp. (JMAC)

Role
Chief Financial Officer, Director
Signature
/s/ Gau, Wey - Chuan (Albert), by Nelson Mullins Riley & Scarborough with Power of Attorney
Stock symbol
JMAC
Transactions as of
Mar 29, 2023
Transactions value $
$0
Form type
4
Date filed
3/29/2023, 05:31 PM
Previous filing
Oct 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JMAC Class A Common Stock Conversion of derivative security +30K 30K Mar 29, 2023 Direct F1
transaction JMAC Class A Common Stock Disposed to Issuer -30K -100% 0 Mar 29, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JMAC Class B Common Stock Conversion of derivative security -30K -100% 0 Mar 29, 2023 Class A Common Stock 30K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Gau Wey - Chuan is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Pursuant to the Business Combination Agreement, dated September 14, 2022, as amended, by and among the Issuer, Apollomics Inc., a Cayman Islands exempted company ("Apollomics"), and Project Max SPAC Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Apollomics ("Merger Sub"), on March 29, 2023 Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Apollomics (the "Business Combination"). As a result of the Business Combination, each share of Class B common stock of the Issuer was automatically converted into one share of Class A common stock of the Issuer.
F2 As a result of the Business Combination, each issued and outstanding share of Class A common stock of the Issuer was exchanged for one Class A ordinary share of Apollomics.